ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Plaque-Hepatic Targeting Nanotherapy Disrupts the PCSK9-LOX-1 Axis to Suppress oxLDL in Atherosclerosis.
Yi Duan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.